Calimmune is a startup based in the United States.
Calimmune is a clinical-stage biotechnology company developing gene-modified cell therapies for the treatment and potential cure of HIV/AIDS and other immune-related diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.